West Pharmaceutical Services, Inc.WSTNYSE

|||

Overview News Chart Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Latest News

defenseworld.net

Head to Head Contrast: West Pharmaceutical Services (NYSE:WST) and Scripsamerica (OTCMKTS:SCRCQ)

Scripsamerica (OTCMKTS:SCRCQ - Get Free Report) and West Pharmaceutical Services (NYSE: WST - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations. Profitability This table compares Scripsamerica and West Pharmaceutical

defenseworld.net

West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of West Pharmaceutical Services, Inc. (NYSE: WST - Get Free Report) have been given a consensus rating of "Moderate Buy" by the fourteen brokerages that are currently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a

defenseworld.net

Caxton Associates LLP Makes New $1.61 Million Investment in West Pharmaceutical Services, Inc. $WST

Caxton Associates LLP bought a new position in shares of West Pharmaceutical Services, Inc. (NYSE: WST) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 7,360 shares of the medical instruments supplier's stock, valued at approximately $1,610,000. Several

defenseworld.net

Headlands Technologies LLC Boosts Stake in West Pharmaceutical Services, Inc. $WST

Headlands Technologies LLC boosted its holdings in West Pharmaceutical Services, Inc. (NYSE: WST) by 326.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,789 shares of the medical instruments supplier's stock after acquiring an additional 6,728 shares during the quarter. Headlands

defenseworld.net

Bamco Inc. NY Sells 108,501 Shares of West Pharmaceutical Services, Inc. $WST

Bamco Inc. NY cut its position in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 26.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 307,647 shares of the medical instruments supplier's stock after selling 108,501 shares during the

prnewswire.com

West to Participate in Upcoming Investor Conference

EXTON, Pa. , Dec. 12, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 9:00 am PST in San Francisco, California.

defenseworld.net

West Pharmaceutical Services, Inc. $WST Shares Acquired by California Public Employees Retirement System

California Public Employees Retirement System increased its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 5.1% during the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 94,256 shares of the medical instruments supplier's stock after acquiring an additional 4,562 shares during the period.

zacks.com

Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now

WST leans on strong HVP demand, rising GLP-1 exposure and Annex 1 tailwinds, even as pricing and device margins weigh on near-term performance.

prnewswire.com

West Declares Quarterly Dividend

EXTON, Pa. , Dec. 10, 2025 /PRNewswire/ -- On December 9, 2025, the board of directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on February 4, 2026, to shareholders of record on January 28, 2026.

seekingalpha.com

Top 50 High-Quality Dividend Growth Stocks For December 2025

I track a custom universe of 50 high-quality dividend growth stocks to identify timely, attractive investment opportunities based on valuation and forward return potential. 28 of these stocks currently offer estimated future returns of at least 10%, with 18 appearing potentially undervalued per my Free Cash Flow model. Top-ranked names like ResMed, Mastercard, and MSCI combine strong projected EPS growth with reasonable valuations.

defenseworld.net

Merit Medical Systems (NASDAQ:MMSI) vs. West Pharmaceutical Services (NYSE:WST) Head to Head Analysis

Merit Medical Systems (NASDAQ: MMSI - Get Free Report) and West Pharmaceutical Services (NYSE: WST - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Analyst Recommendations This is a summary

defenseworld.net

Fisher Asset Management LLC Has $5.33 Million Holdings in West Pharmaceutical Services, Inc. $WST

Fisher Asset Management LLC lessened its holdings in West Pharmaceutical Services, Inc. (NYSE: WST) by 17.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,338 shares of the medical instruments supplier's stock after selling 4,983 shares

seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

247wallst.com

30% of the S&P 500 Is Mag 7 Tech Stocks, but This ETF Refuses to Own a Single One

The Magnificent 7 AI tech stocks have served as the rocket fuel propelling the S&P 500 on its bull run over the past few years.

seekingalpha.com

West Pharmaceutical: Back To Growth

West Pharmaceutical Services is rated a buy, supported by strong Q3 results, raised guidance, and a resilient long-term growth thesis. WST's focus on high-value proprietary elastomer components and secular industry drivers, like GLP-1 demand, underpins robust margin and revenue growth. Risks include questionable capital allocation, recent insider selling during buybacks, and potential disruption from oral drug alternatives.

defenseworld.net

West Pharmaceutical Services, Inc. $WST Shares Acquired by Coldstream Capital Management Inc.

Coldstream Capital Management Inc. increased its stake in West Pharmaceutical Services, Inc. (NYSE: WST) by 19.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,264 shares of the medical instruments supplier's stock after buying an additional 366 shares during

seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Presents at Stephens Annual Investment Conference 2025 Transcript

West Pharmaceutical Services, Inc. ( WST ) Stephens Annual Investment Conference 2025 November 20, 2025 12:00 PM EST Company Participants Robert McMahon - Senior VP & CFO Shane Campbell - SVP & Chief Proprietary Segment Officer John Sweeney - Head of Investor Relations Conference Call Participants Steven Etoch - Stephens Inc., Research Division Presentation Steven Etoch Stephens Inc., Research Division Welcome to day 3 of Stephens 2025 Investment Conference here at Nashville. I'm Mac Etoch, the Life Science Tools and Pharma Services Analyst.

defenseworld.net

Artisan Partners Limited Partnership Grows Stock Holdings in West Pharmaceutical Services, Inc. $WST

Artisan Partners Limited Partnership increased its stake in West Pharmaceutical Services, Inc. (NYSE: WST) by 3.3% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,267,319 shares of the medical instruments supplier's stock after purchasing an additional 71,836 shares during the quarter. Artisan

seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Presents at Jefferies London Healthcare Conference 2025 Transcript

West Pharmaceutical Services, Inc. ( WST ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST Company Participants Robert McMahon - Senior VP & CFO Conference Call Participants David Windley - Jefferies LLC, Research Division Presentation David Windley Jefferies LLC, Research Division Good morning. I'm Dave Windley with Jefferies Healthcare Equity Research.

defenseworld.net

West Pharmaceutical Services, Inc. $WST Shares Sold by Candriam S.C.A.

Candriam S.C.A. lowered its position in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 8.6% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,770 shares of the medical instruments supplier's stock after selling 543 shares during the quarter. Candriam S.C.A.'s

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance